SCHEMBL2863029

SCHEMBL2863029

CC1=CC(C)(C)c2cc3c(cc21)-c1ccccc1C3

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 11/20 0.61
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SRD5A2 P31213 1/20 0.38
CYP1A2 P05177 2/20 0.38
MAOA P21397 2/20 0.38
ADRA2A P08913 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
HTR2B P41595 1/20 0.38
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2863031 0.94 PGR (0.57) PGRALDH1A1KDM4ENPC1LMNA
SCHEMBL2860612 0.88 PGR (0.44) PGRKDM4EAPOBEC3AAPOBEC3G
SCHEMBL22242680 0.82 PGR (0.41) PGR
SCHEMBL21165773 0.81 PGR (0.41) PGRKDM4EAPOBEC3AAPOBEC3G
SCHEMBL2863494 0.80 PGR (0.47) PGRALDH1A1KDM4ENPC1LMNA
SCHEMBL2870966 0.80 PGR (0.47) PGRALDH1A1KDM4ENPC1LMNA
SCHEMBL9370506 0.76 PGR (1.00) PGRALDH1A1KDM4ELMNAMAPT
SCHEMBL3280539 0.74 SMN1; SMN2 (0.61) PGRALDH1A1KDM4ENPC1LMNA
SCHEMBL29924230 0.74 SMN1; SMN2 (0.61) PGRALDH1A1KDM4ENPC1LMNA
SCHEMBL2870970 0.74 PGR (0.44) PGRALDH1A1KDM4ENPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7834204-B2 Fluorene derivative, transition metal compound, catalyst for olefin polymerization, and process for producing olefin polymer MITSUI CHEMICALS, INC. (JP) 2010-11-16 US disclosed
US-20090253876-A1 Fluorene Derivative, Transition Metal Compound, Catalyst for Olefin Polymerization, and Process for Producing Olefin Polymer MITSUI CHEMICALS, INC. 2009-10-08 US disclosed
EP-1900715-A1 FLUORENE DERIVATIVE, TRANSITION METAL COMPOUND, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER Mitsui Chemicals, Inc. (JP) 2008-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253876-A1 Fluorene Derivative, Transition Metal Compound, Catalyst for Olefin Polymerization, and Process for Producing Olefin Polymer AFF4, OR10J3, DRD1 PGR 2102/4885ALDH1A1 3472/4885KDM4E 2909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.